Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Lin, Feng  [Clear All Filters]
2024
Jing S, Ren X, Lin F, Niu H, Ayi Q, Wan B, Zeng B, Zhang X. Water depth-dependent stem elongation of completely submerged is mediated by intra-internodal growth variations. Front Plant Sci. 2024;15:1323547.
2023
Vinikoor T, Dzidotor GK, Le TT, Liu Y, Kan H-M, Barui S, Chorsi MT, Curry EJ, Reinhardt E, Wang H, et al. Injectable and biodegradable piezoelectric hydrogel for osteoarthritis treatment. Nat Commun. 2023;14(1):6257.
Perez JA, Valdes JJParcero, Moreno RCorral, Cuevas LIGomez, Lopez JJ, Ichim T, McGreevy K, Lin F, Kesari S, Datta S. Intravenous Administration of Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSC) for Acute Respiratory Distress Syndrome Due to COVID-19 Infection. Cureus. 2023;15(8):e44110.
Bai L, Han Q, Han Z, Zhang X, Zhao J, Ruan H, Wang J, Lin F, Cui W, Yang X, et al. Stem Cells Expansion Vector via Bioadhesive Porous Microspheres for Accelerating Articular Cartilage Regeneration. Adv Healthc Mater. 2023:e2302327.
2022
Bharti R, Dey G, Lin F, Lathia J, Reizes O. CD55 in cancer: Complementing functions in a non-canonical manner. Cancer Lett. 2022:215935.
2021
Lin F, Zhang S, Liu X, Wu M. Mouse bone marrow derived mesenchymal stem cells-secreted exosomal microRNA-125b-5p suppresses atherosclerotic plaque formation via inhibiting Map4k4. Life Sci. 2021:119249.
2019
Lin F, Shao Y, Xue X, Zheng Y, Li Z, Xiong C, Fu J. Biophysical phenotypes and determinants of anterior vs. posterior primitive streak cells derived from human pluripotent stem cells. Acta Biomater. 2019.
Li Y, Lin F. Decoy nanoparticles bearing native C5a receptors as a new approach to inhibit complement-mediated neutrophil activation. Acta Biomater. 2019.
2018
Lin F, Wen D, Wang X, Mahato RI. Dual responsive micelles capable of modulating miRNA-34a to combat taxane resistance in prostate cancer. Biomaterials. 2018;192:95-108.
2015
Tapper W, Jones AV, Kralovics R, Harutyunyan AS, Zoi K, Leung W, Godfrey AL, Guglielmelli P, Callaway A, Ward D, et al. Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms. Nat Commun. 2015;6:6691.
2014
Li D, Zhao L-N, Zheng X-L, Lin P, Lin F, Li Y, Zou H-F, Cui R-J, Chen H, Yu X-G. Sox2 is involved in paclitaxel resistance of the prostate cancer cell line PC-3 via the PI3K/Akt pathway. Mol Med Rep. 2014.